Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease

被引:75
|
作者
Viasus, Diego [1 ]
Garcia-Vidal, Carolina [1 ]
Cruzado, Josep M. [2 ,3 ]
Adamuz, Jordi [1 ]
Verdaguer, Ricard [4 ]
Manresa, Frederic [3 ,5 ]
Dorca, Jordi [3 ,5 ]
Gudiol, Francesc [1 ,3 ]
Carratala, Jordi [1 ,3 ]
机构
[1] Dept Infect Dis Barcelona, Barcelona, Spain
[2] Hosp Univ Bellvitge, Dept Nephrol, Inst Invest Biomed Bellvitge IDIBELL Barcelona, Barcelona, Spain
[3] Univ Barcelona, Dept Clin Sci, Barcelona, Spain
[4] Univ Barcelona, Dept Microbiol, Barcelona, Spain
[5] Hosp Univ Bellvitge, Dept Resp Med, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain
关键词
chronic kidney disease; epidemiology; mortality; pneumonia; risk factors; COMMUNITY-ACQUIRED PNEUMONIA; CARE-ASSOCIATED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; BLOOD-STREAM INFECTION; PNEUMOCOCCAL VACCINATION; HOSPITALIZED-PATIENTS; IMMUNE DYSFUNCTION; ANTIBIOTIC-THERAPY; ADULT PATIENTS; RISK-FACTORS;
D O I
10.1093/ndt/gfq798
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Although infection remains among the most common causes of morbidity and mortality in patients with chronic kidney disease (CKD), data on epidemiology, clinical features and outcomes of pneumonia in this population are scarce. Methods. Observational analysis of a prospective cohort of hospitalized adults with pneumonia, between 13 February 1995 and 30 April 2010, in a tertiary teaching hospital. CKD patients, defined as patients with a baseline glomerular filtration rate < 60 mL/min/1.73m(2), were compared with non-CKD patients. Results. During the study period, 3800 patients with pneumonia required hospitalization. Two-hundred and three (5.3%) patients had CKD, of whom 46 were on dialysis therapy. Patients with CKD were older (77 versus 70 years; P < 0.001), were more likely to have comorbidities (82.3 versus 63.3%; P < 0.001) and more commonly classified into high-risk pneumonia severity index classes (89.6 versus 57%; P < 0.001) than were the remaining patients. Streptococcus pneumoniae was the most frequent pathogen (28.1 versus 34.7%; P = 0.05). Mortality was higher in patients with CKD (15.8 versus 8.3%; P < 0.001). Among CKD patients, age [+1 year increase; adjusted odds ratio, 1.25; 95% confidence interval (CI) 1.07-1.46] and cardiac complications during hospitalization (adjusted odds ratio, 9.23; 95% CI 1.39-61.1) were found to be independent risk factors for mortality, whereas prior pneumococcal vaccination (adjusted odds ratio, 0.05; 95% CI 0.005-0.69) and leukocytosis at hospital admission (adjusted odds ratio, 0.10; 95% CI 0.01-0.64) were protective factors. Conclusions. Pneumonia is a serious complication in CKD patients. Independent factors for mortality are older age and cardiac complications, whereas prior pneumococcal vaccination and leucokytosis at hospital admission are protective factors. These findings should encourage physicians to increase pneumococcal vaccine coverage among CKD patients.
引用
收藏
页码:2899 / U1510
页数:8
相关论文
共 50 条
  • [21] Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease
    Ravi, Venkatesh
    Iskander, Fady
    Saini, Abhimanyu
    Brecklin, Carolyn
    Doukky, Rami
    [J]. CLINICAL CARDIOLOGY, 2018, 41 (05) : 660 - 665
  • [22] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Patrick, Stephanie A.
    Dabal, Tracey D.
    Jackson, Christopher D.
    Halalau, Alexandra
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (09) : 2915 - 2917
  • [23] Clinical outcomes of patients with stage 4 chronic kidney disease (CKD)
    Conway, B.
    Whitworth, C.
    Harty, J.
    [J]. SCOTTISH MEDICAL JOURNAL, 2006, 51 (04) : 47 - 47
  • [24] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Stephanie A. Patrick
    Tracey D. Dabal
    Christopher D. Jackson
    [J]. Journal of General Internal Medicine, 2021, 36 : 2915 - 2917
  • [25] Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
    Carrero, Juan Jesus
    Hecking, Manfred
    Chesnaye, Nicholas C.
    Jager, Kitty J.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (03) : 151 - 164
  • [26] Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
    Juan Jesus Carrero
    Manfred Hecking
    Nicholas C. Chesnaye
    Kitty J. Jager
    [J]. Nature Reviews Nephrology, 2018, 14 : 151 - 164
  • [27] Epidemiology of cardiovascular risk in patients with chronic kidney disease
    Locatelli, F
    Pozzoni, P
    Tentori, F
    Del Vecchio, L
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 : 2 - 9
  • [28] Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis
    Levin, A
    [J]. SEMINARS IN DIALYSIS, 2003, 16 (02) : 101 - 105
  • [29] Epidemiology of chronic Kidney Disease - are there more and more Patients?
    Kraus, Daniel
    Wanner, Christoph
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (17) : 1276 - 1281
  • [30] Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Held, Claes
    Hou, Fan-Fan
    Mann, Johannes F. E.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    [J]. CIRCULATION, 2021, 143 (05) : 438 - 448